Mahdi Fallah1, Eero Pukkala2, Kristina Sundquist3, Steinar Tretli4, Jörgen H Olsen5, Laufey Tryggvadottir6, Kari Hemminki7. 1. Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. Electronic address: M.Fallah@dkfz.de. 2. Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland; School of Health Sciences, University of Tampere, Tampere, Finland. 3. Center for Primary Health Care Research, Lund University, Malmö, Sweden. 4. Norwegian Cancer Registry, Oslo, Norway. 5. Institute of Cancer Epidemiology, Copenhagen, Denmark. 6. Center for Primary Health Care Research, Lund University, Malmö, Sweden; Norwegian Cancer Registry, Oslo, Norway. 7. Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany; Center for Primary Health Care Research, Lund University, Malmö, Sweden.
Abstract
BACKGROUND: We aimed to estimate lifetime cumulative risk of melanoma (CRM) in relatives of patients with melanoma by histology and age at diagnosis in patients and relatives. METHODS: A population-based cohort of 238724 first-degree relatives of 46091 melanoma patients diagnosed in 1955-2010 in Nordic countries was followed for cancer incidence. FINDINGS: The CRM (0-79 years) in first-degree relatives of a patient with superficial spreading (SSM), nodular (NM), or lentigo maligna melanoma was quite similar, ranging from 2.5% to about 3%, which represents about 2-fold increase over the general population risk. When one melanoma patient in the family was diagnosed before age 30, the CRM was about 3%. When there were > or =2 melanoma patients diagnosed before age 30 in a family, CRM for relatives was about 14%, 6% for diagnoses at age 30-59, and 5% for diagnoses at age 60 or older. Depending on age at diagnosis of same-sex twins (not known whether monozygotic/dizygotic), their CRM was about 7-21%. Although no familial case of concordant histological types of acral lentiginous/desmoplastic/compound nevus/spindle cell melanomas or malignant blue nevus was found, familial risks of discordant histological types of melanoma were interchangeably high for most of the types, e.g. higher risk of SSM when a first-degree relative had NM [standardized incidence ratios (SIR)=2.6, 95% confidence interval (CI)=2.1-3.3, n=72] or acral lentiginous (4.0, 95% CI=1.5-8.8, n=6) and vice versa. There was a tendency toward concordant age at diagnosis of melanoma among relatives of melanoma patients. INTERPRETATION: Findings of this study may help clinicians to find subjects at high melanoma risk for the genetic counseling. The risk was highest when melanoma occurred in a same-sex twin, one first-degree relative diagnosed at young age (<30), or > or =2 first-degree relatives. Histological type of melanoma does not seem to play an important role in familial melanoma. FUNDING: This work was supported by the Nordic Cancer Union, Swedish Council for Working Life and Social Research, and German Cancer Aid.
BACKGROUND: We aimed to estimate lifetime cumulative risk of melanoma (CRM) in relatives of patients with melanoma by histology and age at diagnosis in patients and relatives. METHODS: A population-based cohort of 238724 first-degree relatives of 46091 melanomapatients diagnosed in 1955-2010 in Nordic countries was followed for cancer incidence. FINDINGS: The CRM (0-79 years) in first-degree relatives of a patient with superficial spreading (SSM), nodular (NM), or lentigo maligna melanoma was quite similar, ranging from 2.5% to about 3%, which represents about 2-fold increase over the general population risk. When one melanomapatient in the family was diagnosed before age 30, the CRM was about 3%. When there were > or =2 melanomapatients diagnosed before age 30 in a family, CRM for relatives was about 14%, 6% for diagnoses at age 30-59, and 5% for diagnoses at age 60 or older. Depending on age at diagnosis of same-sex twins (not known whether monozygotic/dizygotic), their CRM was about 7-21%. Although no familial case of concordant histological types of acral lentiginous/desmoplastic/compound nevus/spindle cell melanomas or malignant blue nevus was found, familial risks of discordant histological types of melanoma were interchangeably high for most of the types, e.g. higher risk of SSM when a first-degree relative had NM [standardized incidence ratios (SIR)=2.6, 95% confidence interval (CI)=2.1-3.3, n=72] or acral lentiginous (4.0, 95% CI=1.5-8.8, n=6) and vice versa. There was a tendency toward concordant age at diagnosis of melanoma among relatives of melanomapatients. INTERPRETATION: Findings of this study may help clinicians to find subjects at high melanoma risk for the genetic counseling. The risk was highest when melanoma occurred in a same-sex twin, one first-degree relative diagnosed at young age (<30), or > or =2 first-degree relatives. Histological type of melanoma does not seem to play an important role in familial melanoma. FUNDING: This work was supported by the Nordic Cancer Union, Swedish Council for Working Life and Social Research, and German CancerAid.
Authors: Yelena P Wu; Wendy Kohlmann; Karen Curtin; Zhe Yu; Heidi A Hanson; Mia Hashibe; Bridget G Parsons; Jathine Wong; Joshua D Schiffman; Douglas Grossman; Sancy A Leachman Journal: Cancer Causes Control Date: 2017-12-14 Impact factor: 2.506
Authors: Mary K Tripp; Susan K Peterson; Alexander V Prokhorov; Sanjay S Shete; Jeffrey E Lee; Jeffrey E Gershenwald; Ellen R Gritz Journal: Am J Prev Med Date: 2016-04-07 Impact factor: 5.043
Authors: Karin A W Wadt; Lauren G Aoude; Lotte Krogh; Lone Sunde; Anders Bojesen; Karen Grønskov; Nine Wartacz; Jakob Ek; Morten Tolstrup-Andersen; Mette Klarskov-Andersen; Åke Borg; Steffen Heegaard; Jens F Kiilgaard; Thomas V O Hansen; Kerenaftali Klein; Göran Jönsson; Krzysztof T Drzewiecki; Morten Dunø; Nicholas K Hayward; Anne-Marie Gerdes Journal: PLoS One Date: 2015-03-24 Impact factor: 3.240
Authors: Sanna M M Heikkinen; Laura-Maria Madanat-Harjuoja; Karri J M Seppä; Matti E Rantanen; Elli M Hirvonen; Nea K Malila; Janne M Pitkäniemi Journal: Int J Cancer Date: 2019-06-27 Impact factor: 7.396